NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND (NHS) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 185 transactions totaling $130.9M, demonstrating a bullish sentiment with $127.2M in net insider flow. The most recent transaction on Jul 17, 2025 involved a purchase of 6,000 shares valued at $44.4K.
NHS Insider Activity Summary
Who Is Buying NHS Stock?
No significant insider buying has been recorded for NHS in the recent period.
Who Is Selling NHS Stock?
No significant insider selling has been recorded for NHS in the recent period.
Is NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NHS is bullish with an Insider Alignment Score of 99/100 and a net flow of $127.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
NHS Frequently Asked Questions
Understanding NHS Insider Activity
Insider trading at NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND (NHS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading NHS stock, having executed 185 transactions in the past 90 days. The most active insider is Investment Management, Llc Metlife (Executive), who has made 21 transactions totaling $95.0M.
Related Tools
Track NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND Insider Activity
Get notified when executives and directors at NHS file new Form 4 transactions